Medinotec Inc.
MDNC
$5.00
$0.000.00%
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 24.23% | -48.31% | -1.09% | 79.40% | 70.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.23% | -48.31% | -1.09% | 79.40% | 70.46% |
| Cost of Revenue | 10.03% | -18.08% | -21.87% | 27.15% | 87.37% |
| Gross Profit | 43.20% | -63.54% | 29.33% | 140.24% | 52.12% |
| SG&A Expenses | 89.49% | 185.17% | 82.98% | 272.02% | 94.23% |
| Depreciation & Amortization | 184.00% | 238.37% | -59.90% | -61.54% | -58.10% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.05% | 33.23% | -2.62% | 97.89% | 88.93% |
| Operating Income | -34.81% | -113.49% | 4.78% | 21.32% | 3.08% |
| Income Before Tax | -20.66% | -114.20% | 12.71% | 32.54% | 22.75% |
| Income Tax Expenses | -109.06% | -145.69% | -18.63% | 58.19% | 17.42% |
| Earnings from Continuing Operations | 95.08% | -104.69% | 30.00% | 21.74% | 30.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 95.08% | -104.69% | 30.00% | 21.74% | 30.50% |
| EBIT | -34.81% | -113.49% | 4.78% | 21.32% | 3.08% |
| EBITDA | -29.05% | -110.51% | 1.26% | 16.27% | -2.53% |
| EPS Basic | 94.85% | -105.99% | 0.00% | 50.00% | 31.08% |
| Normalized Basic EPS | -20.71% | -118.63% | -15.72% | 57.61% | 15.70% |
| EPS Diluted | 94.85% | -105.99% | 0.00% | 50.00% | 31.08% |
| Normalized Diluted EPS | -20.71% | -118.63% | -15.72% | 57.61% | 15.70% |
| Average Basic Shares Outstanding | 0.18% | -21.98% | 30.00% | -18.86% | 0.00% |
| Average Diluted Shares Outstanding | 0.18% | -21.98% | 30.00% | -18.86% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |